Shane Wells, MD

I am a board-certified diagnostic radiologist with clinical expertise in genitourinary imaging and intervention, including tumor ablation, with a translational research focus in 1) improving cancer outcomes through novel imaging and image-guided approaches and 2) the development of image-based biomarkers for the lower urinary tract. My interventional research program is focused on optimizing cancer outcomes through improved patient selection, utility and timing of biopsy, and perioperative techniques to improve treatment efficacy and confirmation. My translational research program is focused on developing non-invasive image-based biomarkers (MRI and US) of the prostate and bladder with the goal of guiding personalized diagnosis and treatment of lower urinary tract dysfunction.

• University of Wisconsin–Madison, Madison, United States
  2011 – 2012
  Fellowship
• University of Michigan–Ann Arbor, Ann Arbor, United States
  2007 – 2011
  Chief Resident
• Marshall University, Huntington, United States
  2006 – 2007
  Internship
• Marshall University, Huntington, United States
  2002 – 2006

Interventional Radiology: I am actively developing a novel image-guidance platform that combines hands-free, electronically steerable ultrasound and MRI using a deep-learning approach to create fast, motion-compensated MRI-US fusion for real-time optimized needle-guidance, treatment monitoring and confirmation inside the interventional MRI suite. The overall goal of this research is to improve cancer outcomes and overall survival for patients undergoing tumor ablation procedures.

Image-based Biomarkers: I am actively developing quantitative imaging techniques (MRI and US) of the lower urinary tract, including the bladder, prostate, and urethra, to characterize mechanical and tissue-level changes that occur in aging patients with lower urinary tract symptoms (LUTS). The overall goal of this research is to facilitate a transformative shift from trial-and-error to a personalized approach to patient care.